Biologically targeted dual adaptive and innate nano-Immunotherapy for clear cell renal cell carcinoma treatment
Abstract Background Immunotherapy treatments have significantly improved metastatic renal cell carcinoma (RCC) treatment outcomes. Despite recent advancements, the rates of durable response to immunotherapy remain low, and the toxicity profiles of treatment continue to be high. To address these chal...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Molecular Cancer |
| Online Access: | https://doi.org/10.1186/s12943-025-02382-y |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|